Is Glenmark Life Science Good Bet for Long-Term Investment?
Market Price: - 733.85 Glenmark Life Science list at 751 with just 4% premium on Indian Stock Exchange as on 06 August 2021. Glenmark Life Sciences initial public offering had received strong response from investors as the offer was subscribed 44.17 times during July 27-29, 2021. The Non-institutional investors reserved portion was subscribed 122.54 times, the qualified institutional buyers were subscribed 36.97 times and the retail portion received 14.63 times subscription. Due to downtrend in Pharma Sector, Glenmark Life Science listed at Just 4% Premium after getting good subscription. Glenmark Life Science Limited Glenmark Life Sciences is an API arm of Glen Mark Pharma, a leading drug maker. They are one of the leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs). Who They Are? They are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, they have establi...